AbstrAct
We present a case of a healthy 22 years old who presented with bruising and hematoma following a minor trauma. Investigations showed severe thrombocytopenia but complete hematological investigations did not reveal a cause. An aggressive treatment with steroids, IVIG, anti-D, splenectomy and immunosuppressant proved to be refractory. A subclinical transaminitis prompted an infectious workup which revealed Cytomegalovirus infection. Platelet count improved and remained stable after eradication of Cytomegalovirus. We conclude that infection with CMV should be ruled out in cases of severe refractory immune thrombocytopenic purpura. 
Outcome and Follow up care
In the follow up visits, CMV was detected but not quantifiable and his platelet count was found to be stable and improving.
Past medical history
The patient had a remote history of Hodgkin's disease diagnosed and treated at an outside hospital at 14 years of age.
He had been assured that there was no evidence of recurrence 2 years ago and had not followed up since.
dIscussIon
Immune Thrombocytopenic Purpura is an acute, self-limited disease in the vast majority of children whereas in adults, ITP has an insidious onset, often with a chronic course. The incidence of ITP in adults increases with age and most cases achieve stable remission. 6, 7, 8 . ITP is considered refractory when it presists for more than three months with a platelet count <30X10 9 /l and does not respond to splenectomy and rituximab. 13 In cases of postsplenectomy Several hypotheses have been put forward regarding attribution of virus and bacteria to ITP. While molecular mimicry and chronic infection leading to immune dysregulation are possible, CMV is able to directly infect megakaryocytes and thereby decrease platelet production. 17, 18, 19 This seems to be the best explanation for the failure to respond to any of the conventional ITP therapies, especially as their primary effects are to block platelet destruction, not to stimulate platelet production. 20 Cytomegalovirus has been detected via culture, serologies, antigen assays, PCR, and cytopathology.
Treatment options invariably consist of antivirals, which remained the same for our case. In a study, a combination of both IV ganciclovir and IV cytogam had been used to optimize rapid suppression of the CMV. 5 The same study showed that use of steroids and other immunosuppressive treatment may exacerbate the primary CMV infection and worsen the ITP, or at least prevent it from improving. Also of interest is that, when CMV is controlled by anti-viral therapies, normal treatments for ITP, such as IVIG and splenectomy regain their effectiveness. 5 The response rate of platelet counts following treatment of CMV has seen to vary widely between studies.
The presence of isolated thrombocytopenia with or without history of fever and myalgia, presence of subclinical transaminitis and atypical lymphocytes on smear should incline a clinician to suspect CMV, especially in endemic areas. 
